Literature DB >> 2722877

Elements modulating the block of transcription elongation at the adenovirus 2 attenuation site.

M Kessler1, E Ben-Asher, Y Aloni.   

Abstract

We have previously reported that a block of transcription elongation is functioning in vivo and in vitro within the leader sequences of SV40 and the adenovirus 2 major late transcription units and in the regulation of transcription of the P4 promoter of minute virus of mice. In the present study using the HeLa whole cell extract-Sarkosyl system with adenovirus 2 major late promoter as a template we have analyzed several basic parameters that can contribute to our understanding of the mechanism that regulates the elongation block at the adenovirus 2 attenuation site. We show that the elongation block is augmented at elevated temperatures (40-45 degrees C). The elongation block can be reversed by the addition of 0.2 M NaCl to the transcription reaction and the reversibility is temperature-dependent. Furthermore, while at 30-35 degrees C the elongation block is reversible with dilution of the Sarkosyl, at 40-45 degrees C it is only partially reversible. These results may indicate that a factor(s) is involved in the regulation of the elongation block and/or that the conformation of the transcription complex is temperature dependent. Finally, we show that the extent of the elongation block is dependent on the consecutive T residues at the attenuation site and we discuss the involvement of RNA secondary structure in eliciting the elongation block.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722877

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  The downstream regulatory sequence of the adenovirus type 2 major late promoter is functionally redundant.

Authors:  X C Li; W L Huang; S J Flint
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  In vitro analysis of a transcription termination site for RNA polymerase II.

Authors:  D K Wiest; D K Hawley
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

3.  Control of formation of two distinct classes of RNA polymerase II elongation complexes.

Authors:  N F Marshall; D H Price
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

4.  Analysis of premature termination in c-myc during transcription by RNA polymerase II in a HeLa nuclear extract.

Authors:  L London; R G Keene; R Landick
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

5.  Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure.

Authors:  H Soreq; R Ben-Aziz; C A Prody; S Seidman; A Gnatt; L Neville; J Lieman-Hurwitz; E Lev-Lehman; D Ginzberg; Y Lipidot-Lifson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  In vitro analysis of elongation and termination by mutant RNA polymerases with altered termination behavior.

Authors:  S A Shaaban; E V Bobkova; D M Chudzik; B D Hall
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

7.  RNA footprint mapping of RNA polymerase II molecules stalled in the intergenic region of polyomavirus DNA.

Authors:  F Brabant; N H Acheson
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Transcription elongation in the human c-myc gene is governed by overall transcription initiation levels in Xenopus oocytes.

Authors:  C A Spencer; M A Kilvert
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

9.  Stability of Drosophila RNA polymerase II elongation complexes in vitro.

Authors:  D D Kephart; N F Marshall; D H Price
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

10.  Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro.

Authors:  T Wada; T Takagi; Y Yamaguchi; D Watanabe; H Handa
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.